THE E-TEST FOR ANTIMICROBIAL SUSCEPTIBILITY TESTING OF HELICOBACTER-PYLORI

被引:72
作者
CEDERBRANT, G [1 ]
KAHLMETER, G [1 ]
LJUNGH, A [1 ]
机构
[1] UNIV LUND,DEPT MED MICROBIOL,S-22101 LUND,SWEDEN
关键词
D O I
10.1093/jac/31.1.65
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Antimicrobial susceptibility testing of Helicobacter pylori by conventional means (disc diffusion) is of questionable value because the bacterium grows so slowly. We have determined the susceptibilities of 20 isolates of H. pylori to ampicillin, erythro mycin, gentamicin, metronidazole, rifampicin and tetracycline by the E test, a novel technique for measuring MICs, and compared the results with those determined by standard agar dilution and disc diffusion methods. Eighty-one per cent of E test determined MICs were within one two-fold dilution and 93% were within two two-fold dilutions of those determined by the reference agar dilution method. MICs determined by the E test were highly reproducible; replicate results were invariably within one two-fold dilution. MICs were not affected by the size of the inoculum, preincubation or incubation times. Regression lines for disc diffusion could not be determined because of the lack of resistant strains. However, metronidazole-resistant strains (MIC >32 mg/L) were easily distinguishable from susceptible strains (MIC <1 mg/L). In conclusion, the E test is a reliable method for determining the antimicrobial susceptibility of H. pylori. © 1993 The British Society for Antimicrobial Chemotherapy.
引用
收藏
页码:65 / 71
页数:7
相关论文
共 12 条
[1]   COMPARISON OF THE E-TEST TO AGAR DILUTION, BROTH MICRODILUTION, AND AGAR DIFFUSION SUSCEPTIBILITY TESTING TECHNIQUES BY USING A SPECIAL CHALLENGE SET OF BACTERIA [J].
BAKER, CN ;
STOCKER, SA ;
CULVER, DH ;
THORNSBERRY, C .
JOURNAL OF CLINICAL MICROBIOLOGY, 1991, 29 (03) :533-538
[2]  
BOLMSTROM A, 1988, 28TH INT C ANT AG CH, P325
[3]   EVALUATION OF THE E-TEST, A NOVEL METHOD OF QUANTIFYING ANTIMICROBIAL ACTIVITY [J].
BROWN, DFJ ;
BROWN, L .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 27 (02) :185-190
[4]   PROPOSED MECHANISM FOR METRONIDAZOLE RESISTANCE IN HELICOBACTER-PYLORI [J].
CEDERBRANT, G ;
KAHLMETER, G ;
LJUNGH, A .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1992, 29 (02) :115-120
[5]   SUSCEPTIBILITY OF CLINICAL ISOLATES OF CAMPYLOBACTER-PYLORI TO 24 ANTIMICROBIAL AND ANTI-ULCER AGENTS [J].
GLUPCZYNSKI, Y ;
DELMEE, M ;
BRUCK, C ;
LABBE, M ;
AVESANI, V ;
BURETTE, A .
EUROPEAN JOURNAL OF EPIDEMIOLOGY, 1988, 4 (02) :154-157
[6]  
GLUPCZYNSKI Y, 1990, REV ESPANOLA ENFERME
[7]   PREVENTION OF NITROIMIDAZOLE RESISTANCE IN CAMPYLOBACTER-PYLORI BY COADMINISTRATION OF COLLOIDAL BISMUTH SUBCITRATE - CLINICAL AND INVITRO STUDIES [J].
GOODWIN, CS ;
MARSHALL, BJ ;
BLINCOW, ED ;
WILSON, DH ;
BLACKBOURN, S ;
PHILLIPS, M .
JOURNAL OF CLINICAL PATHOLOGY, 1988, 41 (02) :207-210
[8]  
KAHLMETER G, 1989, 1ST SCAND M BACT GOT
[9]  
KNAPP CC, 1990, 13TH INT C ANT AG CH, P232
[10]   SUSCEPTIBILITY OF CAMPYLOBACTER-PYLORIDIS TO 20 ANTIMICROBIAL AGENTS [J].
LAMBERT, T ;
MEGRAUD, F ;
GERBAUD, G ;
COURVALIN, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 30 (03) :510-511